2018
DOI: 10.1007/s11606-018-4527-2
|View full text |Cite
|
Sign up to set email alerts
|

Industry Payments to Academic Physicians: a Comparison of Reporting to Two Government Agencies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…First, our study relied on Open Payments data for identification of receipt of payments which may may underreport physicians' receipt of payments. 31 Second, we constructed our physician networks based on Medicare data; therefore, the networks of physicians may vary when including non-Medicare patients. However, this data is unique in its completeness of capturing all Medicare interactions, whereas prior work has had to construct networks based on much smaller geographic samples.…”
Section: Discussionmentioning
confidence: 99%
“…First, our study relied on Open Payments data for identification of receipt of payments which may may underreport physicians' receipt of payments. 31 Second, we constructed our physician networks based on Medicare data; therefore, the networks of physicians may vary when including non-Medicare patients. However, this data is unique in its completeness of capturing all Medicare interactions, whereas prior work has had to construct networks based on much smaller geographic samples.…”
Section: Discussionmentioning
confidence: 99%
“…These findings add to prior studies of industry marketing of opioid products, which have focused exclusively on payments made to individual physicians. 2,3 As a result of Open Payments database limitations which include reliance on company self-report 6 and a high frequency of companies not reporting which product payments were linked to, our analyses may underestimate payments related to opioids made to teaching hospitals. As Open Payments provides limited information on reasons for payments beyond broadly defined categories, some payments may be related to improving education on safe prescribing or risk evaluation programs.…”
Section: Discussionmentioning
confidence: 99%